SOLICITATION NOTICE
B -- Evaluation of Methods for Systematically Discerning the Effects of Polytherapy on Drug Safety Profiles.
- Notice Date
- 9/3/2003
- Notice Type
- Solicitation Notice
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Division of Contracts and Procurement Management, Office of Facilities, Acquisitions, and Central Svcs 5600 Fishers Lane, HFA-511, Rockville, MD, 20857
- ZIP Code
- 20857
- Solicitation Number
- Reference-Number-D78040
- Response Due
- 9/18/2003
- Archive Date
- 10/3/2003
- Point of Contact
- Stephanie Hawk, Buyer, Phone 301-827-7886, Fax 301-594-2127,
- E-Mail Address
-
hawks@cder.fda.gov
- Small Business Set-Aside
- Total Small Business
- Description
- This is a combined synopsis/solicitation for commercial items or services prepared in accordance with the format in FAR Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a written solicitation will not be issued. This solicitation is issued as a Request for Quote (RFQ) No. D78040. These solicitation clauses and provisions are those in effect through Federal Acquisition Circular 97-27. The Standard Industrial Classification (SIC) Code for this acquisition is 7379 and the North American Classification System (NAICS) Code is 541511. The FDA intends to issue a purchase order on a sole source basis to Lincoln Technologies, Inc. for the following service entitled: Evaluation of Methods for Systematically Discerning the Effects of Polytherapy on Drug Safety Profiles. The Contractor will furnish the following categories of software and services; 1. Design, implement and test scalable, high-performance software (stand-alone version) embodying DuMouchel’s naïve Bayes method for determining Polytherapy Bias Adjustment Factors. 2. Install stand-alone PBAF program at FDA. Provide written usage instructions. Perform initial testing and validation of the stand-alone program in collaboration with the FDA Principal Investigator. 3. Integrate the software into the existing MGPS program and construct interface to WebVDME. 4. Install enhanced WebVDME/MGPS at FDA and integrate with the current CBAERS database. Assist FDA with testing and evaluation activities. Provide written usage instructions. Period of performance is six months from the date of the award. The following FAR Clauses shall apply to this solicitation: 52.212-1 Instructions to Offerors-Commercial; 52.212-4 Contract Terms and Conditions-Commercial Items; and 52.232-33 Electronic Funds Transfers. All responsible sources that can provide and meet the above requirements shall submit written quotations by the due date referenced above. The award is being issued on a sole source basis because Lincoln Technologies is uniquely qualified because they have been key participants in the design and implementation of the data mining software currently being used by the FDA. They have hands-on experience in working with the AERS data in several different formats and have consulted extensively to FDA in the design of graphical techniques for summarizing safety data mining output. They are uniquely familiar with the rule set for the registration system and issues involved in defining it. FAR provisions can be found on the following website: http://www/arnet.gov.
- Web Link
-
Link to FedBizOpps document.
(http://www.eps.gov/spg/HHS/FDA/DCPM/Reference-Number-D78040/listing.html)
- Place of Performance
- Address: FDA/CDER/OPaSS/OB/QMRS 5600 Fishers Lane Rockville, Maryland
- Zip Code: 20857
- Country: USA
- Zip Code: 20857
- Record
- SN00424829-F 20030905/030903214157 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |